Advertisement

Related Videos

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Deborah Collyar: What's In It for Patients?

Peter Clark, MA, MD, FRCP: A Payer Perspective

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Apr
11
Today In Oncology
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
American Cancer Society Announces New Pediatric Adolescent and Young Adult Cancer Journal
Colorectal Cancer Duloxetine Not Effective in Preventing Oxaliplatin-Induced Peripheral Neuropathy
Advanced Prostate Cancer Radiographic Progression and PSA Increase in Patients Treated With Enzalutamide
CLL Linked to Increased Skin Cancer Risk and Mortality
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo